These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Nevada
|
26-0287664
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
Page
|
||
|
PART I - FINANCIAL INFORMATION
|
||
|
Item 1. Financial Statements.
|
3
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
12
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
|
16
|
|
|
Item 4. Controls and Procedures.
|
16
|
|
|
PART II - OTHER INFORMATION
|
||
|
Item 1. Legal Proceedings.
|
17
|
|
|
Item 1A. Risk Factors.
|
17
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
|
17
|
|
|
Item 3. Defaults Upon Senior Securities.
|
17
|
|
|
Item 4. (Removed and Reserved).
|
17
|
|
|
Item 5. Other Information.
|
17
|
|
|
Item 6. Exhibits.
|
18
|
|
|
SIGNATURES
|
19
|
|
|
September 30, 2011
|
December 31, 2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$ | 1,311,881 | $ | 238,424 | ||||
|
Accounts receivable
|
37,500 | - | ||||||
|
Work in progress
|
136,473 | - | ||||||
|
Prepaid expenses
|
230,857 | 86,996 | ||||||
|
Other receivables
|
5,883 | 14,018 | ||||||
|
TOTAL CURRENT ASSETS
|
1,722,594 | 339,438 | ||||||
|
PROPERTY & EQUIPMENT
|
||||||||
|
Machinery and equipment
|
27,783 | 1,372 | ||||||
|
Furniture and fixtures
|
27,056 | 27,056 | ||||||
|
Computer equipment
|
26,304 | 26,304 | ||||||
|
Leasehold improvements
|
94,914 | 94,914 | ||||||
| 176,057 | 149,646 | |||||||
|
Less accumulated depreciation
|
(123,029 | ) | (114,927 | ) | ||||
|
NET PROPERTY & EQUIPMENT
|
53,028 | 34,719 | ||||||
|
OTHER ASSETS
|
||||||||
|
Equity Investment
|
20,000 | - | ||||||
|
Patent
|
152,618 | 84,833 | ||||||
|
Trademark
|
4,467 | 4,467 | ||||||
|
Security deposit
|
9,650 | 9,650 | ||||||
|
TOTAL OTHER ASSETS
|
186,735 | 98,950 | ||||||
|
TOTAL ASSETS
|
$ | 1,962,357 | $ | 473,107 | ||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable
|
$ | 127,972 | $ | 56,288 | ||||
|
Accrued expenses
|
78,066 | 46,942 | ||||||
|
Deferred income
|
350,663 | - | ||||||
|
Derivative liability
|
476,599 | - | ||||||
|
Convertible debenture, net of discount
|
208,947 | - | ||||||
|
Other payables
|
- | 8,461 | ||||||
|
TOTAL LIABILITIES
|
1,242,247 | 111,691 | ||||||
|
SHAREHOLDERS' EQUITY
|
||||||||
|
Preferred stock, $0.0001 par value;
|
||||||||
|
1,666,667 authorized preferred shares
|
- | - | ||||||
|
Common stock, $0.0001 par value;
|
||||||||
|
16,666,667 authorized common shares
|
||||||||
|
7,537,160 and 6,153,656 shares issued and outstanding
|
753 | 615 | ||||||
|
Additional paid in capital
|
15,284,269 | 11,524,341 | ||||||
|
Common stock subscription payable
|
- | 184,500 | ||||||
|
Deficit accumulated during the development stage
|
(14,564,912 | ) | (11,348,040 | ) | ||||
|
TOTAL SHAREHOLDERS' EQUITY
|
720,110 | 361,416 | ||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$ | 1,962,357 | $ | 473,107 | ||||
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30, 2011
|
September 30, 2010
|
September 30, 2011
|
September 30, 2010
|
|||||||||||||
|
Sales
|
$ | - | $ | - | $ | 142,500 | $ | - | ||||||||
|
Cost of Goods Sold
|
- | - | - | - | ||||||||||||
|
Gross Profit
|
- | - | 142,500 | - | ||||||||||||
|
Operating Expenses
|
||||||||||||||||
|
Selling, general and administrative expenses
|
1,141,494 | 1,139,328 | 2,629,791 | 2,255,909 | ||||||||||||
|
Research and development cost
|
333,484 | 192,179 | 723,917 | 538,527 | ||||||||||||
|
Total Operating Expenses
|
1,474,978 | 1,331,507 | 3,353,708 | 2,794,436 | ||||||||||||
|
Loss before Depreciation and Amortization
|
(1,474,978 | ) | (1,331,507 | ) | (3,211,208 | ) | (2,794,436 | ) | ||||||||
|
Depreciation and amortization
|
3,202 | 15,251 | 8,102 | 42,235 | ||||||||||||
|
Loss from Operatings before Other Income/(Expense)
|
(1,478,180 | ) | (1,346,758 | ) | (3,219,310 | ) | (2,836,671 | ) | ||||||||
|
Other Income/(Expense)
|
||||||||||||||||
|
Interest income
|
- | - | 1 | 6 | ||||||||||||
|
Dividend income
|
- | 1 | - | 32 | ||||||||||||
|
Gain/(Loss) on derivative
|
462,643 | - | 462,643 | - | ||||||||||||
|
Amortization of debt discount
|
(444,247 | ) | - | (444,247 | ) | - | ||||||||||
|
Penalties
|
- | - | (2,384 | ) | - | |||||||||||
|
Interest expense
|
(13,038 | ) | - | (13,575 | ) | - | ||||||||||
|
Total Other Income/(Expenses)
|
5,358 | 1 | 2,438 | 38 | ||||||||||||
|
Loss before Provision for Taxes
|
(1,472,822 | ) | (1,346,757 | ) | (3,216,872 | ) | (2,836,633 | ) | ||||||||
|
Income taxes
|
- | - | - | - | ||||||||||||
|
Net Loss
|
$ | (1,472,822 | ) | $ | (1,346,757 | ) | $ | (3,216,872 | ) | $ | (2,836,633 | ) | ||||
|
Basic and Diluted Loss per Share
|
$ | (0.22 | ) | $ | (0.24 | ) | $ | (0.49 | ) | $ | (0.52 | ) | ||||
|
Weighted-Average Common Shares Outstanding
|
||||||||||||||||
|
Basic and Diluted
|
6,794,747 | 5,629,903 | 6,583,507 | 5,450,185 | ||||||||||||
|
Deficit
|
||||||||||||||||||||||||
|
Accumulated
|
||||||||||||||||||||||||
|
Additional
|
Common
|
during the
|
||||||||||||||||||||||
|
Common stock
|
Paid-in
|
Stock
|
Development
|
|||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Payable
|
Stage
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2010
|
6,153,656 | $ | 615 | $ | 11,524,341 | $ | 184,500 | $ | (11,348,040 | ) | $ | 361,416 | ||||||||||||
|
Share adjustment due to reverse split (unaudited)
|
126 | - | - | - | - | - | ||||||||||||||||||
|
Common stock issued for cash and subscription payable
|
||||||||||||||||||||||||
|
(price per share $2,40) (unaudited)
|
1,187,382 | 119 | 2,849,556 | (184,500 | ) | - | 2,665,175 | |||||||||||||||||
|
Warrants issued at fair value for marketing services (unaudited)
|
- | - | 12,440 | - | - | 12,440 | ||||||||||||||||||
|
Common stock issued for services at fair value (unaudited)
|
33,333 | 3 | 151,247 | - | - | 151,250 | ||||||||||||||||||
|
Cashless exercise of warrants (unaudited)
|
62,718 | 6 | (6 | ) | - | - | - | |||||||||||||||||
|
Conversion of convertible debentures into common stock
|
||||||||||||||||||||||||
|
(price per share $2.40) (unaudited)
|
98,043 | 10 | 296,048 | - | - | 296,058 | ||||||||||||||||||
|
Common stock issued for interest on convertible debentures
|
||||||||||||||||||||||||
|
(price per share $2.40) (unaudited)
|
1,902 | - | 4,564 | - | - | 4,564 | ||||||||||||||||||
|
Options and warrant compensation expense (unaudited)
|
- | - | 539,519 | - | - | 539,519 | ||||||||||||||||||
|
Stock issuance cost (unaudited)
|
- | - | (93,440 | ) | - | - | (93,440 | ) | ||||||||||||||||
|
Net loss for the nine months ended September 30, 2011 (unaudited)
|
- | - | - | - | (3,216,872 | ) | (3,216,872 | ) | ||||||||||||||||
|
Balance at September 30, 2011 (unaudited)
|
7,537,160 | $ | 753 | $ | 15,284,269 | $ | - | $ | (14,564,912 | ) | $ | 720,110 | ||||||||||||
|
Nine Months Ended
|
||||||||
|
September 30, 2011
|
September 30, 2010
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net loss
|
$ | (3,216,872 | ) | $ | (2,836,633 | ) | ||
|
Adjustment to reconcile net loss to net cash
|
||||||||
|
used in operating activities
|
||||||||
|
Depreciation & amortization
|
8,102 | 42,235 | ||||||
|
Common stock issued for services
|
151,250 | 210,511 | ||||||
|
Stock compensation expense
|
539,519 | 442,942 | ||||||
|
Common stock issued for interest expense
|
4,564 | - | ||||||
|
Gain on change in valuation of derivative liability
|
(462,643 | ) | - | |||||
|
Amortization of debenture discount
|
444,247 | - | ||||||
|
Changes in Assets and Liabilities
|
||||||||
|
(Increase) Decrease in:
|
||||||||
|
Accounts receivable
|
(37,500 | ) | - | |||||
|
Prepaid expenses
|
(148,418 | ) | (16,900 | ) | ||||
|
Other receivables
|
8,135 | (2,100 | ) | |||||
|
Work in progress
|
(136,473 | ) | (54,005 | ) | ||||
|
Increase (Decrease) in:
|
||||||||
|
Accounts payable
|
76,241 | 17,083 | ||||||
|
Accrued expenses
|
31,124 | 36,145 | ||||||
|
Deferred income
|
350,663 | 13,500 | ||||||
|
Other payable
|
(8,461 | ) | 19 | |||||
|
NET CASH USED IN OPERATING ACTIVITIES
|
(2,396,522 | ) | (2,147,203 | ) | ||||
|
CASH FLOWS USED FROM INVESTING ACTIVITIES:
|
||||||||
|
Purchase of investment
|
(20,000 | ) | - | |||||
|
Patent and trademark expenditures
|
(67,785 | ) | (14,197 | ) | ||||
|
Purchase of fixed assets
|
(26,411 | ) | (4,036 | ) | ||||
|
NET CASH USED IN INVESTING ACTIVITIES
|
(114,196 | ) | (18,233 | ) | ||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Proceeds from convertible debenture
|
1,000,000 | - | ||||||
|
Proceeds from common stock subscription payable
|
- | 902,486 | ||||||
|
Proceeds for issuance of common stock
|
2,665,175 | 1,034,122 | ||||||
|
Stock issuance cost
|
(81,000 | ) | ||||||
|
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
3,584,175 | 1,936,608 | ||||||
|
NET INCREASE/(DECREASE) IN CASH
|
1,073,457 | (228,828 | ) | |||||
|
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD
|
238,424 | 356,179 | ||||||
|
CASH & CASH EQUIVALENTS, END OF PERIOD
|
$ | 1,311,881 | $ | 127,351 | ||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
|
Interest paid
|
$ | 537 | $ | - | ||||
|
Taxes paid
|
$ | - | $ | - | ||||
|
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS
|
||||||||
|
Cashless exercise of warrants for 62,718 of common stock
|
$ | - | $ | - | ||||
| Common stock issued for subscription payable | $ | 184,500 | $ | - | ||||
| Conversion of convertible debt to common stock | $ | 296,058 | $ | - | ||||
|
1.
|
Basis of Presentation
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
|
|
·
|
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
|
|
·
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
|
·
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
Total
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
|||||||||||||
|
Assets
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Total assets measured at fair value
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Liabilities
|
||||||||||||||||
|
Derivative Liability
|
$ | 476,599 | $ | - | $ | - | $ | 476,599 | ||||||||
|
Convertible Debenture, net of discount
|
208,947 | - | - | 208,947 | ||||||||||||
|
Total liabilities measured at fair value
|
$ | 685,546 | $ | - | $ | - | $ | 685,546 | ||||||||
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
|
|
|
Recently Issued Accounting Pronouncements
|
|
|
The Company adopted ASC 815 "Accounting for Derivative Instruments and Hedging Activities"
.
This pronouncement addresses the accounting for derivative instruments including certain derivative instruments embedded in other contracts, and hedging activities. Derivative instruments that meet the definition of assets and liabilities should be reported in the financial statements at fair value, and any gain or loss should be recognized in current earnings. The adoption of this pronouncement did not have a material effect on the financial statements of the Company.
|
|
3.
|
EQUITY INVESTMENT
|
|
4.
|
CAPITAL STOCK
|
|
5.
|
STOCK OPTIONS AND WARRANTS
|
|
9/30/2011
|
||||
|
Risk free interest rate
|
0.95%-2.04 | % | ||
|
Stock volatility factor
|
55.16%-271.95 | % | ||
|
Weighted average expected option life
|
5 years
|
|||
|
Expected dividend yield
|
None
|
|||
|
5.
|
STOCK OPTIONS AND WARRANTS (Continued)
|
|
9/30/2011
|
||||||||
|
Weighted
|
||||||||
|
Number
|
average
|
|||||||
|
of
|
exercise
|
|||||||
|
Options
|
price
|
|||||||
|
Outstanding, beginning of period
|
498,292 | $ | 7.10 | |||||
|
Granted
|
100,000 | 4.20 | ||||||
|
Exercised
|
- | - | ||||||
|
Forfeited/Expired
|
(225,829 | ) | (6.88 | ) | ||||
|
Outstanding, end of period
|
372,463 | $ | 6.45 | |||||
|
Exercisable at the end of period
|
98,249 | $ | 4.01 | |||||
|
Weighted average fair value of
|
||||||||
|
options granted during the period
|
$ | 4.20 | ||||||
|
Weighted
|
||||||||||||||
|
Average
|
||||||||||||||
|
Stock
|
Stock
|
Remaining
|
||||||||||||
|
Exercisable
|
Options
|
Options
|
Contractual
|
|||||||||||
|
Prices
|
Outstanding
|
Exercisable
|
Life (years)
|
|||||||||||
| $ | 9.60 | 6,250 | 2,853 | 1.75 | ||||||||||
| $ | 6.90 | 209 | 58 | 1.75 | ||||||||||
| $ | 9.60 | 68,000 | 35,292 | 2.93 | ||||||||||
| $ | 8.40 | 3,334 | 1,650 | 3.03 | ||||||||||
| $ | 9.00 | 15,000 | 7,356 | 3.05 | ||||||||||
| $ | 6.90 | 81,669 | 27,901 | 3.64 | ||||||||||
| $ | 7.20 | 1,667 | 426 | 3.98 | ||||||||||
| $ | 4.50 | 33,334 | 7,117 | 4.15 | ||||||||||
| $ | 6.00 | 63,000 | 8,267 | 4.48 | ||||||||||
| $ | 4.20 | 100,000 | 7,329 | 4.72 | ||||||||||
| 372,463 | 98,249 | |||||||||||||
|
9/30/2011
|
||||
|
Risk free interest rate
|
1.51% - 2.51 | % | ||
|
Stock volatility factor
|
55.0% - 66.35 | % | ||
|
Weighted average expected option life
|
5 years
|
|||
|
Expected dividend yield
|
None
|
|||
|
5.
|
STOCK OPTIONS AND WARRANTS (Continued)
|
|
Nine Months Ended
|
||||||||
|
September 30, 2011
|
||||||||
|
Weighted
|
||||||||
|
average
|
||||||||
|
exercise
|
||||||||
|
Options
|
price
|
|||||||
|
Outstanding -beginning of Period
|
1,273,271 | $ | 4.97 | |||||
|
Granted
|
79,003 | 3.76 | ||||||
|
Exercised
|
(62,718 | ) | - | |||||
|
Forfeited
|
(6,667 | ) | 2.10 | |||||
|
Outstanding - end of Period
|
1,282,889 | $ | 4.09 | |||||
|
Weighted
|
||||||||||||||
|
Average
|
||||||||||||||
|
Remaining
|
||||||||||||||
|
Exercisable
|
Warrants
|
Warrants
|
Contractual
|
|||||||||||
|
Prices
|
Outstanding
|
Exercisable
|
Life (years)
|
|||||||||||
| $ | 7.50 | 146,740 | 146,740 | 2.18 | ||||||||||
| $ | 9.30 | 336,673 | 336,673 | 2.75 | ||||||||||
| $ | 10.20 | 28,335 | 28,335 | 2.88 | ||||||||||
| $ | 9.00 | 21,669 | 21,669 | 3.07 | ||||||||||
| $ | 9.00 | 3,334 | 3,334 | 3.12 | ||||||||||
| $ | 8.70 | 3,334 | 3,334 | 3.12 | ||||||||||
| $ | 8.40 | 667 | 667 | 3.33 | ||||||||||
| $ | 8.70 | 5,000 | 5,000 | 3.66 | ||||||||||
| $ | 7.20 | 33,334 | 33,334 | 3.73 | ||||||||||
| $ | 5.70 | 7,334 | 7,334 | 3.85 | ||||||||||
| $ | 4.50 | 3,334 | 3,334 | 3.96 | ||||||||||
| $ | 4.20 | 8,334 | 8,334 | 3.98 | ||||||||||
| $ | 2.10 | 95,238 | 95,238 | 4.24 | ||||||||||
| $ | 4.20 | 33,334 | 33,334 | 4.00 | ||||||||||
| $ | 3.60 | 8,334 | 8,334 | 4.08 | ||||||||||
| $ | 4.50 | 33,334 | 33,334 | 4.15 | ||||||||||
| $ | 4.20 | 13,334 | 13,334 | 4.17 | ||||||||||
| $ | 6.00 | 166,668 | 166,668 | 4.23 | ||||||||||
| $ | 6.00 | 33,334 | 33,334 | 4.25 | ||||||||||
| $ | 1.80 | 222,222 | 222,222 | 4.33 | ||||||||||
| $ | 6.30 | 8,334 | 8,334 | 4.47 | ||||||||||
| $ | 5.70 | 4,001 | 4,001 | 4.50 | ||||||||||
| $ | 6.30 | 33,334 | 33,334 | 4.71 | ||||||||||
| $ | 4.20 | 33,334 | 33,334 | 4.96 | ||||||||||
| 1,282,889 | 1,282,889 | |||||||||||||
|
6.
|
CONVERTIBLE DEBENTURE
|
|
Stock price on the valuation date
|
$ | 4.20 | ||
|
Conversion price for the debentures
|
$ | 2.40 | ||
|
Dividend yield
|
0.00 | % | ||
|
Years to Maturity
|
1 | |||
|
Rick free rate
|
0.17 | % | ||
|
Expected volatility
|
65.75 | % |
|
7.
|
SUBSEQUENT EVENTS
|
|
|
Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following events:
|
|
.
|
On October 12, 2011, the Company issued 13,333 shares of its common stock in connection with renewing their facilities lease. In consideration of the shares issued the sublease was renewed for an additional five years ending August 31, 2016.
|
|
|
On October 13 and 18, 2011, the Company issued an aggregate of 41,668 shares of the common stock, upon converting $100,003 in principal of the convertible debentures.
|
|
●
|
business strategy;
|
|
|
●
|
financial strategy;
|
|
|
●
|
intellectual property;
|
|
|
●
|
production;
|
|
|
●
|
future operating results; and
|
|
|
●
|
plans, objectives, expectations and intentions contained in this report that are not historical.
|
|
-
|
On January 25, 2011, we announced that MBD Energy Ltd. (“MBD”) had committed to purchase an initial OriginOil extraction unit for piloting at one of Australia’s three largest coal-fired power plants. The total value of the purchase order was $150,000, and the initial payment received was $75,000. The next payments due are as follows: $37,500 upon notification ready to ship, and the balance of $37,500 shall be due upon installation.
|
|
-
|
On February 14, 2011 we announced that we had agreed to participate in a pilot scale algae project to be funded by the Mexican government. The project is intended to demonstrate industrial algae production, paving the way for substantial investment by the Mexican government in large-scale jet fuels production.
|
|
-
|
On March 21, 2011, we announced Algae Screen™, a process that keeps algae healthy and productive by selectively eliminating microscopic predators without the use of chemicals. The announcement was associated with our filing of our twelfth patent application, entitled “Enhancing Algae Growth by Reducing Competing Microorganisms in a Growth Medium.”
|
|
-
|
On March 24, 2011, we agreed to retain the patent law firm of Kirton & McConkie, and subsequently ended our relationship with Workman Nydegger.
|
|
-
|
On March 28, 2011, we announced a new policy of seamless integration with other vendors, recognizing that our strategic customers want to work with the fewest possible vendors. The new policy will apply only to OriginOil’s direct customers, as we plan to pursue distribution agreements with companies that have global sales networks.
|
|
-
|
On April 12, 2011, we announced that a process partner, World Water Works, Inc. of Oklahoma City, Oklahoma, agreed in principle to distribute OriginOil’s dewatering and extraction systems to its global customer base. The agreement covers product integration, manufacturing and joint marketing.
|
|
-
|
On May 9, 2011, we announced that we formed a co-venture for technology development with BARD Holding, Inc. (“BARD”) of Morrisville, Pensylvania, focusing on BARD’s BA 1000, a patent-pending modular system of Photo BioReactors (PBRs) to cultivate algae at commercial scale, and OriginOil’s harvesting and extraction technology. On 30 April, 2011, we executed a co-venture agreement with BARD, pursuant to which we shall sell equipment and related services to BARD from time to time under the terms of a global cooperation agreement.
|
|
-
|
On May 11, 2011, we announced our participation in Ennesys SAS, a French joint venture with UK-based Pacific Junction (PJC UK), and that Ennesys is working with large institutions to develop two separate large-scale algae projects in eco-buildings and marine fuels. OriginOil is an equity partner in Ennesys with Pacific Junction, each holding 22.5% of Ennesys. The remaining shares are owned by the Ennesys management team. On April 29, 2011, we paid PJC UK $20,000 for its shares, which PJC UK had reserved for OriginOil at the inception of Ennesys SAS in late 2010. On April 26, 2011, we executed a co-venture agreement with Ennesys, pursuant to which we shall sell equipment and related services to Ennesys from time to time under the terms of a global cooperation agreement.
|
|
-
|
On May 23, 2011, we announced that we received a firm order for a large-scale extraction system from MBD. Recently, MBD increased the order due to changes in configuration, and issued a purchase order on July 29, 2010. The total value of the purchase order is $850,000 of which $297,500 or 35% was paid on August 5, 2011.
|
|
-
|
On July 27, 2011, we announced that we have selected Pacific Advanced Civil Engineering, Inc. to fast-track the rollout of our Single Step Extraction systems.
|
|
-
|
On August 4, 2011, we announced that we have developed a real-time control network to supervise continuous algae harvesting operations at very large algae productions sites.
|
|
-
|
On September 1, 2011, we announced that our delegates to the Algae World Australia Conference toured our next-generation algae extraction technology at a university-staffed site in North Queens Land, Australia.
|
|
-
|
On September 20, 2011, we announced that we will begin to work with the U.S. Department of Energy's Idaho National Laboratory to develop standards for converting biomass, including algae, into biofuels and other products.
|
|
-
|
On September 29, 2011, we announced that we have identified a new process to increase the efficiency of algae extraction without the use of toxic solvents.
|
|
-
|
On October 11, 2011, we announced that our first Single Step Extraction™ Production System had been shipped to Australia.
|
|
| - | On October 27, 2011, we announced that our recent development of a new harvest pretreatment process was also found to substantially increase the growth rate of algae cultures. |
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
2011
(Unaudited)
|
September 30,
2010
(Unaudited)
|
September 30,
2011
(Unaudited)
|
September 30,
2010
(Unaudited)
|
|||||||||||||
|
Revenue
|
$
|
0
|
$
|
0
|
$
|
142,500
|
$
|
0
|
||||||||
|
Operating Expenses
|
$
|
1,474,978
|
$
|
1,331,507
|
$
|
3,353,708
|
$
|
2,794,436
|
||||||||
|
Loss from Operations before Other Income/(Expense)
|
$
|
(1,478,180)
|
$
|
(1,346,758)
|
$
|
(3,219,310)
|
$
|
(2,836,671)
|
||||||||
|
Other Income/(Expense)
|
$
|
5,358
|
$
|
1
|
$
|
2,438
|
$
|
38
|
||||||||
|
Loss Before Provision For Taxes
|
(1,472,822)
|
(1,346,757)
|
(3,216,872)
|
(2,836,633)
|
||||||||||||
|
Income Taxes
|
0
|
0
|
0
|
0
|
||||||||||||
|
Net Loss
|
$
|
(1,472,822)
|
$
|
(1,346,757)
|
$
|
(3,216,872)
|
$
|
(2,836,633)
|
||||||||
|
Exhibit
Number
|
Description of Exhibit
|
|
|
31.1
|
Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
|
|
|
32.1
|
Certification by Chief Executive Officer and Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code.
|
|
|
101.INS
|
XBRL Instance Document.*
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema.*
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase.*
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase.*
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase.*
|
|
|
101.PRE
|
XBRL Extension Presentation Linkbase.*
|
|
*
|
Attached as Exhibit 101 to this report are the following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statement of Operations, (iii) the Statement of Shareholders’ Equity, (iv) the Statement of Cash Flow, and (v) Notes to Financial Statements tagged as blocks of text. The XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed “filed” or as part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended and is not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of those sections.
|
|
ORIGINOIL, INC.
|
|||
|
By:
|
/s/ T Riggs Eckelberry | ||
|
T Riggs Eckelberry
|
|||
|
Chief Executive Officer (Principal Executive Officer)
|
|||
|
and Acting Chief Financial Officer (Principal Accounting and Financial Officer)
|
|||
|
November 14, 2011
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|